文献速递中药与中成药合理使用

基于谱效关系的草珊瑚蛋白聚糖活性结构基础研究

Bioactive structural basis of proteoglycans from Sarcandra glabra based on spectrum-effect relationship.
PubMed 文献 · J Ethnopharmacol · 2020-05-07

该研究以18批草珊瑚蛋白聚糖为对象,建立HPSEC、PMP-HPLC和FT-IR多元指纹图谱,测定抗肿瘤与抗氧化活性,并用化学计量学分析谱效关系。结果表明,葡萄糖醛酸、木糖、岩藻糖、β-糖苷键、肽键和亚甲基等结构标记与抑制MG63和U2OS细胞活性相关;木糖、葡萄糖醛酸和葡萄糖胺等为抗氧化活性标记。

要点

  • 草珊瑚蛋白聚糖的抗肿瘤活性结构标记包括GlcA、Xyl、Fuc、β-糖苷键、肽键和亚甲基。
  • 抗氧化活性标记为Xyl、GlcA、GlcN及吡喃环、羧基、肽键和亚甲基结构。
  • 谱效关系分析可用于关联中药大分子糖缀合物的结构与药效。

核心结论

  • 基于谱效关系分析可发现影响草珊瑚蛋白聚糖药效的物质基础,为探索中药大分子糖缀合物结构与药效关系奠定基础。

研究设计与样本

  • 研究建立18批草珊瑚蛋白聚糖样品的HPSEC、PMP-HPLC和FT-IR多元指纹图谱,并测定抗肿瘤与抗氧化活性,采用化学计量学方法分析谱效关系。

主要发现

  • PCA结果显示木糖、鼠李糖、葡萄糖醛酸、酸性糖中羧基、蛋白质中肽键和亚甲基可作为区分不同来源样品的标记。
  • PLS-DA谱效关系分析表明,抑制MG63和U2OS细胞活性的生物活性标记与GlcA、Xyl、Fuc、β-糖苷键、肽键和亚甲基相关。
  • 抗氧化活性标记为Xyl、GlcA和GlcN,组标记为吡喃环、羧基、肽键和亚甲基结构。

临床怎么用

  • 可将GlcA、Xyl、Fuc、β-糖苷键、肽键和亚甲基等结构标记用于草珊瑚蛋白聚糖抗肿瘤活性的质量评价。
  • 可将Xyl、GlcA、GlcN及吡喃环、羧基、肽键和亚甲基结构用于抗氧化活性的关联分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Proteoglycans are one of the active ingredients of great importance in Sarcandra glabra. The biological activities of proteoglycans extracted from Sarcandra glabra including suppressing tumor growth and antioxidant activity were studied. However, raw materials from different regions may cause differences in the activity of natural extracts, especially for bioactive biomacromolecules. Conventional identification of S.glabra cannot accurately reflect the distinguishing relationship between internal components and the pharmacological activity. The identification of biologically active structures was obtained by constructing multiple fingerprint and spectrum-effect relationship. AIM OF THE STUDY: To evaluate the bioactive structural basis of proteoglycans from S.glabra based on spectrum-effect relationship and chemometric methods. MATERIALS AND METHODS: Multiple fingerprinting including HPSEC, PMP-HPLC, and FT-IR of proteoglycans was established from 18 batches of samples based on the structural characteristics. Both antitumor activity and antioxidant activity were determined. Mathematical analysis was used to analyze the spectrum-effect relationship. RESULTS: PCA results showed monosaccharides including Xly, Rha, and GlcA, carboxyl group in acidic sugars, peptide bond in proteins, and methylene groups could be used as markers for distinguishing the samples from different sources. The results of the spectrum-effect relationship analysis indicated that the bioactive markers of inhibitory activity on MG63 and U2OS cells by PLS-DA were related to GlcA, Xyl, Fuc, β-glycosidic bonds, peptide linkage, and methylene groups. Markers composing monosaccharide for antioxidant activity were Xyl, GlcA, and GlcN. Meanwhile, the group markers were pyranose ring, carboxyl group, peptide linkage, and methylene structure. CONCLUSIONS: The material basis that affects the pharmacological efficacy could be found according to the spectrum-effect relationship analysis. This study could lay a foundation for further exploring the relationship between structural characteristics and pharmacodynamics of macromolecular glycoconjugates in Traditional Chinese Medicine.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Sun X, Zhao Q, Si Y, et al. Bioactive structural basis of proteoglycans from Sarcandra glabra based on spectrum-effect relationship. J Ethnopharmacol. 2020. PMID: 32389856. doi:10.1016/j.jep.2020.112941

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。